Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 207
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Monaldi Arch Chest Dis ; 92(4)2022 Feb 17.
Artículo en Inglés | MEDLINE | ID: mdl-35172568

RESUMEN

The incidence rate of tuberculosis in developed countries is low. The most common presentation of this disease is its pulmonary form but with the increasing use of immunosuppressive drugs, extra-pulmonary tuberculosis is re-emerging. Nevertheless, sternal bone involvement is uncommon. We report the case of an eighty-three-year-old man who presented a painful sternal mass which progressed towards cutaneous ulceration. The first diagnostic hypothesis was neoplasia. The pathological and microbiological diagnosis of tuberculosis was achieved after surgical biopsy. The patient received treatment against tuberculosis for nine months enabling recovery without surgery. This case illustrates the importance of having a diagnosis prior to any kind of treatment facing any voluminous parietal thoracic lesions.  This diagnosis is made possible by surgical samples and interdisciplinary teamwork. This case underlines that tuberculosis remains a differential diagnosis that must be evoked in case of unusual bone mass.


Asunto(s)
Ilusiones , Neoplasias Torácicas , Pared Torácica , Tuberculosis , Anciano de 80 o más Años , Humanos , Masculino , Esternón/microbiología , Esternón/patología , Neoplasias Torácicas/diagnóstico , Tuberculosis/diagnóstico
2.
Heart Surg Forum ; 24(4): E741-E745, 2021 08 25.
Artículo en Inglés | MEDLINE | ID: mdl-34473026

RESUMEN

BACKGROUND: Despite improvements over time with regard to morbidity, mortality, and long-term survival, deep sternal wound infection (DSWI) continues to be a major complication after open-heart surgery. This is why it is important to identify possible risk factors for postoperative development of DSWI in patients undergoing coronary artery bypass grafting and valve replacement. The aim of this study was to identify the risk factors for postoperative development of deep sternal wound infection in patients after coronary artery bypass grafting and heart defect surgery at the Department of Thoracic, Cardiac, and Vascular Surgery of the Hospital of Lithuanian University of Health Sciences. METHODS: This retrospective study analyzed 201 patients, who underwent coronary artery bypass grafting and heart defect surgery between January 2017 and December 2018. The case group contained 45 patients, who had to be reoperated because of deep sternal wound infection, and the control group consisted of 156 randomly selected patients. For descriptive statistics, we used means, median values, ranges, standard deviations, and 95% confidence intervals, where appropriate. Categorical data were analyzed using the chi-square or Fisher's exact test. Student T-test and Mann-Whitney used to compare numerical variables. Logistic regression model adjusting for age and gender was used to compare the risk of infection. A P-value of < 0.05 was considered to be statistically significant. SPSS 26.0 was used for calculations. RESULTS: Logistic regression analysis revealed that independent risk factors for sternal wound infection were high BMI (odds ratio [OR] 1.15, CI 1.06-1.24), preoperative CRP (OR 1.08, CI 1.01-1.16), long duration of cardiopulmonary bypass (OR 1.02, CI 1.01-1.03), intraoperative anemia (OR 0.97, CI 0.95-0.99), and postoperative CRP concentration (OR 1.10; CI 1.05-1.16). CONCLUSIONS: Preoperative assessment to identify obese individuals as being at risk and techniques to minimize the duration of surgery and intraoperative blood loss may help reduce postoperative deep sternal wound infections.


Asunto(s)
Puente de Arteria Coronaria/efectos adversos , Enfermedad Coronaria/cirugía , Cardiopatías Congénitas/cirugía , Esternón/microbiología , Infección de la Herida Quirúrgica/etiología , Anciano , Anemia/complicaciones , Índice de Masa Corporal , Proteína C-Reactiva/metabolismo , Enfermedad Coronaria/sangre , Femenino , Cardiopatías Congénitas/sangre , Humanos , Masculino , Persona de Mediana Edad , Tempo Operativo , Complicaciones Posoperatorias , Factores de Riesgo
3.
J Intensive Care Med ; 35(8): 805-809, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-30089431

RESUMEN

BACKGROUND: There is no consensus for the length of prophylactic antibiotics after delayed chest closure (DCC) postcardiac surgery in pediatrics. In September 2014, our institution's pediatric cardiac intensive care unit changed the policy on length of prophylactic antibiotics after DCC from 5 days (control) to 2 days (study group). The objective of the study was to determine whether a 2-day course of antibiotics is as effective as a 5-day course in preventing blood stream and sternal wound infections in pediatric DCC. METHODS: Retrospective and prospective study. Primary end points included incidence of sternal wound infections and positive sternal imaging for infection. Surrogate markers of infection were collected at 4 time points. RESULTS: During the study period, 139 patients had DCC postcardiac surgery of which 110 patients were included for analysis, 54 patients in the control and 56 in the study group. There was no difference in total number of positive wound cultures/chest computed tomography (CT) findings (4/54 [7.5%] control vs 5/56 [8.9%] study group, P = .3), positive blood cultures (P = .586), median postsurgical length of stay (P = .4), or readmissions within 30 days postsurgery (P = .6). All secondary end points were similar in both groups except peak heart rate between weeks 2 and 4 (P = .041). CONCLUSION: Two days of prophylactic antibiotics is not inferior to 5 days of prophylactic antibiotics after DCC following pediatric cardiac surgery.


Asunto(s)
Profilaxis Antibiótica/métodos , Procedimientos Quirúrgicos Cardíacos/efectos adversos , Cuidados Posoperatorios/métodos , Sepsis/prevención & control , Infección de la Herida Quirúrgica/prevención & control , Profilaxis Antibiótica/normas , Biomarcadores/sangre , Niño , Preescolar , Esquema de Medicación , Femenino , Humanos , Lactante , Masculino , Pediatría/métodos , Pediatría/normas , Cuidados Posoperatorios/normas , Estudios Prospectivos , Estudios Retrospectivos , Esternón/microbiología , Esternón/cirugía , Factores de Tiempo , Tomografía Computarizada por Rayos X
4.
Pediatr Crit Care Med ; 21(2): 150-155, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-31568260

RESUMEN

OBJECTIVES: Vacuum-assisted closure is being increasingly used to treat deep sternal wound infection following cardiac surgery, but most of the data refer to adults. This study investigated the safety and efficacy of vacuum-assisted closure in pediatric patients. DESIGN: Retrospective file review. SETTING: Tertiary pediatric medical center. PATIENTS: All children with deep sternal wound infection treated with vacuum-assisted closure in 2003-2016. INTERVENTIONS: Epidemiological, clinical, and microbiological data were collected from the medical records. MEASUREMENTS AND MAIN RESULTS: The cohort included 50 patients (0.9% of cardiac patients operated during the study period) of median age 6.5 months (interquartile range, 2-12.75 mo; range, 1 wk to 14 yr) and median weight 5.1 kg (interquartile range, 4-9.75 kg). The most frequent heart defects were tetralogy of Fallot (22%) and ventricular septal defect (20%); 38% of patients had cyanotic heart disease. Deep sternal wound infections appeared a median of 10 days postoperatively (interquartile range, 7-14 d; range 3-100 d). Vacuum-assisted closure was applied a median of 13 days postoperatively (interquartile range, 10-18.5 d; range, 5-103 d) for a median duration of 10 days (interquartile range, 7-13.25 d; range, 1-21 d). Wound cultures were positive in 48 patients (96%); most isolates were Gram-positive (76%). The main bacterial pathogen was methicillin-susceptible Staphylococcus aureus (61%). Most patients were treated with cloxacillin for a median of 38 days (interquartile range, 28-42 d; range, 9-189 d). There were no statistically significant differences in clinical or treatment characteristics between bacteremic (56%) and nonbacteremic patients. Compared with older patients, infants less than 3 months old (36%) had a significantly longer hospitalization time (41 vs 25 d; p = 0.001) and higher Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery Mortality Category (3 vs 2; p = 0.003). All cases except one (contact dermatitis) were uneventful. In 10 patients, wounds were closed surgically after vacuum-assisted closure. Two patients required a pectoralis flap, both treated before 2005. One of the two deaths was infection-related. CONCLUSIONS: Vacuum-assisted closure is a feasible treatment option of deep sternal wound infection after pediatric cardiac surgery and was not associated with independent morbidity.


Asunto(s)
Procedimientos Quirúrgicos Cardíacos/efectos adversos , Terapia de Presión Negativa para Heridas/métodos , Esternón/cirugía , Infección de la Herida Quirúrgica/terapia , Adolescente , Antibacterianos/uso terapéutico , Bacterias/aislamiento & purificación , Procedimientos Quirúrgicos Cardíacos/métodos , Niño , Preescolar , Cloxacilina/uso terapéutico , Femenino , Humanos , Lactante , Recién Nacido , Tiempo de Internación , Masculino , Estudios Retrospectivos , Esternotomía/métodos , Esternón/microbiología , Infección de la Herida Quirúrgica/etiología , Resultado del Tratamiento , Cicatrización de Heridas
5.
Int Wound J ; 17(4): 1019-1027, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32298049

RESUMEN

Deep sternal wound infection (DSWI) is a severe complication in patients after open heart surgery (OHS). But there is a lack of appropriate imaging tool to detect the infection sites, which may lead to incomplete debridement. The present study aims to investigate the value of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (18 F-FDG PET/CT) in comparison with CT scan in diagnosing and localising DSWI. A total of 102 patients with DSWI after OHS were retrospectively collected from January 2012 to December 2017 in our hospital. All the patients had surgical debridements for DSWI with pretreatment imaging of either 18 F-FDG PET/CT or CT scan. The sensitivity, specificity, and accuracy of localising infection sites were compared between PET/CT and CT groups, with surgical, microbiological, and histopathological findings as the gold standard. The length of hospital stays and the rate of recurrence were also compared. Ten patients in the PET/CT group had a follow-up PET/CT scan after debridement, and the correlations between the changes of PET/CT findings and surgical outcomes were analysed. 18 F-FDG PET/CT is more accurate than CT in diagnosing and localising DSWI after OHS, which leads to a more successful surgical debridement with a lower rate of recurrence and a shorter length of hospital stay. In addition, follow-up PET/CT after debridement could evaluate the treatment effect.


Asunto(s)
Desbridamiento/métodos , Fluorodesoxiglucosa F18 , Tomografía Computarizada Cuatridimensional/métodos , Imágenes en Psicoterapia/métodos , Tomografía Computarizada por Tomografía de Emisión de Positrones/métodos , Infección de Heridas/diagnóstico , Infección de Heridas/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Esternón/microbiología
6.
Khirurgiia (Mosk) ; (5): 34-41, 2020.
Artículo en Ruso | MEDLINE | ID: mdl-32500687

RESUMEN

OBJECTIVE: To evaluate bacterial flora in patients with deep sternal wound infection and the effect of negative pressure wound therapy on eradication of the pathogen. MATERIAL AND METHODS: There were 102 patients with deep wound infection after cardiac surgery. Mean age was 66.9±9.9 years. Diabetes mellitus was detected in 21 (20.5%) cases, chronic obstructive pulmonary disease - in 15 (14.7%). Wound debridement via daily dressings was performed in 64 patients; vacuum-assisted dressings were applied in 38 patients. Bacteriological analysis of discharge was carried out every week.Results. Mixed infection was observed in 38 (37.3%) patients. S.aureus was the most common pathogen (n=51, 50%), Gram negative bacteria were found in 36 (35.3%) patients. Negative pressure wound therapy ensured eradication of S.aureus within 3 weeks while dressings were associated with only 40% decrease of the incidence of positive analyses (p<0.05). Effectiveness of the method was not obtained for Gram negative bacteria. CONCLUSION: Negative pressure wound therapy accelerates eradication of Gram positive pathogens but does not affect eradication of Gram negative microbes.


Asunto(s)
Procedimientos Quirúrgicos Cardíacos/efectos adversos , Terapia de Presión Negativa para Heridas , Infecciones Estafilocócicas/terapia , Esternotomía/efectos adversos , Infección de la Herida Quirúrgica/microbiología , Infección de la Herida Quirúrgica/terapia , Anciano , Procedimientos Quirúrgicos Cardíacos/métodos , Desbridamiento , Farmacorresistencia Microbiana , Infecciones por Bacterias Gramnegativas/etiología , Infecciones por Bacterias Gramnegativas/microbiología , Infecciones por Bacterias Gramnegativas/terapia , Infecciones por Bacterias Grampositivas/microbiología , Infecciones por Bacterias Grampositivas/terapia , Humanos , Persona de Mediana Edad , Infecciones Estafilocócicas/etiología , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/aislamiento & purificación , Esternón/microbiología , Esternón/cirugía , Infección de la Herida Quirúrgica/etiología
8.
J Antimicrob Chemother ; 71(2): 460-3, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26518048

RESUMEN

OBJECTIVES: Dalbavancin, a semi-synthetic lipoglycopeptide, is characterized by a long plasma half-life, which allows weekly dosing. Dalbavancin may be a good treatment option for patients with deep sternal wound infections owing to its improved pharmacokinetic profile and antibacterial activity compared with currently used antibiotics. Here we evaluated the efficacy of 7 or 14 days of treatment with dalbavancin, compared with vancomycin and with saline, in reducing sternal bone MRSA counts in a rat Staphylococcus aureus deep sternal wound infection model. METHODS: A mid-sternal wound was surgically induced in anaesthetized rats. A clinical strain of MRSA was injected into the sternum to establish infection. Rats were treated intraperitoneally for 7 or 14 days with dalbavancin, vancomycin or saline. The number of cfu per gram of sternum or spleen tissue was determined using viable counts. The antibacterial efficacy was determined by the reduction in bacterial counts per gram of sternum or spleen tissue in each treatment group. RESULTS: Treatment with dalbavancin was superior to treatment with saline for 7 days (0.75 log reduction in bone cfu) or 14 days (>3 log reduction in bone cfu) and similar to treatment with vancomycin. Additionally, dalbavancin was also effective in reducing systemic dissemination of MRSA. CONCLUSIONS: Dalbavancin is effective in the treatment of MRSA rat sternal osteomyelitis.


Asunto(s)
Antibacterianos/uso terapéutico , Mediastinitis/tratamiento farmacológico , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Osteomielitis/tratamiento farmacológico , Infecciones Estafilocócicas/tratamiento farmacológico , Teicoplanina/análogos & derivados , Infección de Heridas/tratamiento farmacológico , Animales , Carga Bacteriana , Modelos Animales de Enfermedad , Masculino , Mediastinitis/complicaciones , Staphylococcus aureus Resistente a Meticilina/aislamiento & purificación , Osteomielitis/complicaciones , Ratas , Bazo/microbiología , Infecciones Estafilocócicas/microbiología , Esternón/microbiología , Esternón/patología , Teicoplanina/uso terapéutico , Resultado del Tratamiento , Vancomicina/uso terapéutico , Infección de Heridas/complicaciones
9.
World J Surg ; 40(11): 2673-2680, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27283188

RESUMEN

BACKGROUND: Recent national infection control efforts have been directed at reducing postsurgical infection rates, related morbidity, and cost. We sought to evaluate population-level rates of deep sternal wound infection (DSWI) after cardiac surgery, associated mortality, and resource use compared to patients undergoing cardiac surgery without postoperative DSWI relative to historical trends. METHODS: We analyzed the MarketScan ® Commercial Claims Databases from 2009 to 2013 to identify adult patients who developed DSWI after open cardiac surgery. Patients with and without DSWI were compared. The outcomes of interest included 30-day, 90-day, and 1-year in-hospital mortality. Utilization outcomes, including total hospital days and inpatient costs, were calculated in the time period from the index cardiac surgery through 90 days after DSWI diagnosis. RESULTS: In this cohort, 176,537 patients underwent one or more cardiac surgery procedures. DSWI occurred in 2835 (1.6 %) patients. One-year mortality for patients with DSWI was 10.7 versus 2.5 % (P < 0.001) in patients without DSWI. Mean hospital days in patients with DSWI were 33 versus 9 days for patients without DSWI (P < 0.001). Mean cost for patients with DSWI was greater than 2.5 times that of patients without DSWI ($211,478 vs $82,089, P < 0.001). CONCLUSIONS: Treatment of DSWI results in substantial morbidity, mortality, and excess cost for treating facilities. The rates of DSWI have not decreased dramatically over the last 10-20 years. Thus, more attention needs to be focused toward understanding treatment variation that exists in patients diagnosed with DSWI.


Asunto(s)
Procedimientos Quirúrgicos Cardíacos/efectos adversos , Recursos en Salud/estadística & datos numéricos , Esternón/microbiología , Esternón/cirugía , Infección de la Herida Quirúrgica/mortalidad , Anciano , Costo de Enfermedad , Femenino , Mortalidad Hospitalaria , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Infección de la Herida Quirúrgica/economía , Infección de la Herida Quirúrgica/epidemiología , Infección de la Herida Quirúrgica/etiología , Estados Unidos/epidemiología
10.
Artículo en Inglés | MEDLINE | ID: mdl-26513908

RESUMEN

Mycobacterium tuberculosis can infect multiple organs and may rarely cause osteomyelitis of the sternum. We report a patient with primary sternal tuberculosis who presented with a chest wall mass. A core needle biopsy confirmed the diagnosis-of tuberculosis. We review the literature regarding tuberculous osteomyelitis of the sternum.


Asunto(s)
Mycobacterium tuberculosis/aislamiento & purificación , Esternón/microbiología , Tuberculosis/diagnóstico , Adulto , Femenino , Humanos , Osteomielitis/microbiología , Tuberculosis Osteoarticular
11.
Wiad Lek ; 68(1): 95-8, 2015.
Artículo en Polaco | MEDLINE | ID: mdl-26094341

RESUMEN

The authors presents case report of a 59-years-old man with triple vessel coronary artery disease, hypertension after myocardial infarction of the inferior wall with sternal wound complcations after coronary bypass grafting (CABG). On the fourth postoperative day the patient developed sternal dehiscence with wound infection. Infection was caused by Staphylococcus haemolyticus--coagulase-negative methicillin-resistant strain, MRCNS. An antimicrobial therapy and negative pressure wound therapy were used for complete wound healing.


Asunto(s)
Puente de Arteria Coronaria/efectos adversos , Enfermedad de la Arteria Coronaria/cirugía , Infarto del Miocardio/cirugía , Infecciones Estafilocócicas/microbiología , Staphylococcus haemolyticus/aislamiento & purificación , Esternón/lesiones , Infección de la Herida Quirúrgica/microbiología , Enfermedad de la Arteria Coronaria/complicaciones , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/complicaciones , Esternón/microbiología
12.
Artículo en Ruso | MEDLINE | ID: mdl-26016348

RESUMEN

AIM: Study of the role of P. aeruginosa in the development of osteomyelitis of sternum and ribs in cardio-surgery patients, and analysis of the main biological properties of the isolated bacterial strains. MATERIALS AND METHODS: 132 bacterial cultures were isolated from 83 hospital patients as a result of bacteriological examination during 2007-2013. Wound discharge was the study mate- rial. Sampling, seeding and identification of the isolated cultures was carried out by using the respective test-systems; antibiotic sensitivity was studied by disc-diffusion method. RESULTS: The proportion of P. aeruginosa was 10.6% (n = 14) that is comparable with data on wound infections of general surgery hospitals. A direct and strong correlation (R = 0.846, p = 0.000132) between hemolytic and phospholipase activity was established during evaluation of virulence properties of the isolated-strains. The degree of film-forming ability varied significantly from 0.122 to 1.412 OD; 64.3% ofthe studied cultures were highly film-forming variants. Statistically significant association between biofilm formation and other studied properties was not found. 4 strains produced VIM2-type metallo-betalactamase and had identical RAPD profiles. CONCLUSION: Considering that earlier the similar cultures were not detected and all of them were isolated at a short interval of time, we have made a conclusion, that their short-term circulation is probably associated with introduction, which was the reason for patient infection. P. aeruginosa could be the etio-pathogen of both early and later complications of cardio-surgical interventions.


Asunto(s)
Osteomielitis/microbiología , Complicaciones Posoperatorias , Infecciones por Pseudomonas/microbiología , Pseudomonas aeruginosa/genética , Costillas/microbiología , Esternón/microbiología , Infección de la Herida Quirúrgica/microbiología , Antibacterianos/farmacología , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Biopelículas , Procedimientos Quirúrgicos Cardíacos , Pruebas Antimicrobianas de Difusión por Disco , Exudados y Transudados/microbiología , Expresión Génica , Hemólisis , Humanos , Osteomielitis/etiología , Osteomielitis/patología , Fosfolipasas/genética , Fosfolipasas/metabolismo , Infecciones por Pseudomonas/etiología , Infecciones por Pseudomonas/patología , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/enzimología , Pseudomonas aeruginosa/aislamiento & purificación , Estudios Retrospectivos , Costillas/patología , Federación de Rusia , Esternón/patología , Infección de la Herida Quirúrgica/etiología , Infección de la Herida Quirúrgica/patología , beta-Lactamasas/genética , beta-Lactamasas/metabolismo
13.
Eur J Clin Microbiol Infect Dis ; 33(3): 325-9, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24030718

RESUMEN

Methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis after median sternotomy is a major complication of cardiac surgery with significant morbidity and mortality rates. We evaluated the efficacy of ceftobiprole medocaril in a new rat model of mediastinitis and compared it to vancomycin. The model was induced in 92 rats. Infection was induced immediately after median sternotomy by the injection of MRSA (strain 3020, 1 × 10(7) cfu/rat) into the sternal bone. After 24 h, rats (groups of 6-8) were treated intraperitoneally for 5 days or 14 days by either: (i) saline (control, q8h), (ii) ceftobiprole medocaril (70 or 100 mg/kg, q8h), or (iii) vancomycin (50 mg/kg, q12h). Efficacy was determined by a reduction in bacterial cfu in the sternum and spleen tissues. Comparisons were performed using the Mann-Whitney test. A 5-day treatment course of ceftobiprole at both doses tested lead to a significant reduction in MRSA load in the sternum (p < 0.01) as compared to the control group and compared to 5-day vancomycin treatment, which lead to a non-significant reduction (p = 0.07). Longer treatment (14 days) with ceftobiprole lead to a complete clearance of MRSA from the sternum, similarly to vancomycin. Ceftobiprole also showed a significant effect on eliminating MRSA dissemination to the spleen compared to saline-treated rats. Ceftobiprole was effective in treating MRSA mediastinitis in the rat model. In the 5-day course, ceftobiprole showed a significant reduction in sternal MRSA counts and was superior to vancomycin. After 14 days, both ceftobiprole and vancomycin showed clearance of MRSA from the sternum in more than 50 % of rats and almost complete clearance in the remainder.


Asunto(s)
Antibacterianos/uso terapéutico , Cefalosporinas/uso terapéutico , Mediastinitis/tratamiento farmacológico , Staphylococcus aureus Resistente a Meticilina/aislamiento & purificación , Infecciones Estafilocócicas/tratamiento farmacológico , Animales , Modelos Animales de Enfermedad , Masculino , Mediastinitis/microbiología , Ratas , Infecciones Estafilocócicas/microbiología , Esternón/microbiología
14.
Thorac Cardiovasc Surg ; 62(3): 258-60, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23344749

RESUMEN

Although osteomyelitis is a very rare complication of Bacillus Calmette-Guérin (BCG) vaccination, sternal osteomyelitis as a late complication of BCG vaccination diagnosed by polymerase chain reaction (PCR) in a child is described.We might consider BCG osteomyelitis in the case of osteomyelitis without bacterial isolation within a year after BCG vaccination, the absence of pulmonary foci, and a contact to the patient with tuberculosis.


Asunto(s)
Vacuna BCG/efectos adversos , Mycobacterium bovis/aislamiento & purificación , Osteomielitis/microbiología , Esternón/microbiología , Tuberculosis Osteoarticular/microbiología , Vacunación/efectos adversos , Antituberculosos/uso terapéutico , Técnicas de Tipificación Bacteriana , Terapia Combinada , ADN Bacteriano/genética , Humanos , Lactante , Masculino , Mycobacterium bovis/clasificación , Mycobacterium bovis/genética , Osteomielitis/diagnóstico , Osteomielitis/terapia , Osteotomía , Reacción en Cadena de la Polimerasa , Valor Predictivo de las Pruebas , Esternón/diagnóstico por imagen , Esternón/cirugía , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , Tuberculosis Osteoarticular/diagnóstico , Tuberculosis Osteoarticular/terapia
15.
Sci Rep ; 14(1): 9690, 2024 04 27.
Artículo en Inglés | MEDLINE | ID: mdl-38678140

RESUMEN

Despite evidence suggesting the benefit of prophylactic regional antibiotic delivery (RAD) to sternal edges during cardiac surgery, it is seldom performed in clinical practice. The value of topical vancomycin and gentamicin for sternal wound infections (SWI) prophylaxis was further questioned by recent studies including randomized controlled trials (RCTs). The aim of this systematic review and meta-analysis was to comprehensively assess the safety and effectiveness of RAD to reduce the risk of SWI.We screened multiple databases for RCTs assessing the effectiveness of RAD (vancomycin, gentamicin) in SWI prophylaxis. Random effects meta-analysis was performed. The primary endpoint was any SWI; other wound complications were also analysed. Odds Ratios served as the primary statistical analyses. Trial sequential analysis (TSA) was performed.Thirteen RCTs (N = 7,719 patients) were included. The odds of any SWI were significantly reduced by over 50% with any RAD: OR (95%CIs): 0.49 (0.35-0.68); p < 0.001 and consistently reduced in vancomycin (0.34 [0.18-0.64]; p < 0.001) and gentamicin (0.58 [0.39-0.86]; p = 0.007) groups (psubgroup = 0.15). Similarly, RAD reduced the odds of SWI in diabetic and non-diabetic patients (0.46 [0.32-0.65]; p < 0.001 and 0.60 [0.44-0.83]; p = 0.002 respectively). Cumulative Z-curve passed the TSA-adjusted boundary for SWIs suggesting adequate power has been met and no further trials are needed. RAD significantly reduced deep (0.60 [0.43-0.83]; p = 0.003) and superficial SWIs (0.54 [0.32-0.91]; p = 0.02). No differences were seen in mediastinitis and mortality, however, limited number of studies assessed these endpoints. There was no evidence of systemic toxicity, sternal dehiscence and resistant strains emergence. Both vancomycin and gentamicin reduced the odds of cultures outside their respective serum concentrations' activity: vancomycin against gram-negative strains: 0.20 (0.01-4.18) and gentamicin against gram-positive strains: 0.42 (0.28-0.62); P < 0.001. Regional antibiotic delivery is safe and effectively reduces the risk of SWI in cardiac surgery patients.


Asunto(s)
Antibacterianos , Profilaxis Antibiótica , Gentamicinas , Ensayos Clínicos Controlados Aleatorios como Asunto , Infección de la Herida Quirúrgica , Vancomicina , Humanos , Infección de la Herida Quirúrgica/prevención & control , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéutico , Profilaxis Antibiótica/métodos , Vancomicina/administración & dosificación , Gentamicinas/administración & dosificación , Gentamicinas/uso terapéutico , Esternón/cirugía , Esternón/microbiología , Procedimientos Quirúrgicos Cardíacos/efectos adversos
16.
Indian J Med Microbiol ; 48: 100562, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38508492

RESUMEN

Gordonia bronchialis is an aerobic gram-positive bacilli and also weakly acid fast. It requires a long incubation time and extensive biochemical reactions for identification. Therefore, use of broad-range polymerase chain reaction (PCR) for amplification of genes such as 16S rRNA or hsp65 followed by sequencing or advanced techniques like MALDI-TOF MS is needed for identification. Here, we present a case of persistent sternal wound infection following open heart surgery, caused by G. bronchialis in a 58 years old male, identified using MALDI-TOF MS-based system. The patient improved with oral Cefpodoxime 200 mg BD for four weeks.


Asunto(s)
Infecciones por Actinomycetales , Esternón , Infección de la Herida Quirúrgica , Humanos , Masculino , Persona de Mediana Edad , Infección de la Herida Quirúrgica/microbiología , Infección de la Herida Quirúrgica/tratamiento farmacológico , Infección de la Herida Quirúrgica/diagnóstico , Esternón/microbiología , Esternón/cirugía , Infecciones por Actinomycetales/microbiología , Bacteria Gordonia/genética , Bacteria Gordonia/aislamiento & purificación , Antibacterianos/uso terapéutico , Procedimientos Quirúrgicos Cardíacos/efectos adversos , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Recurrencia , ARN Ribosómico 16S/genética
17.
J Surg Res ; 185(1): 64-9, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23809152

RESUMEN

BACKGROUND: We aimed to investigate the influence of intraperitoneal ozone therapy on bacterial elimination and mediastinal inflammation in experimental Staphylococcus aureus mediastinitis. MATERIALS AND METHODS: Forty Wistar-Albino rats were randomized into five groups (eight per group) as follows: uncontaminated group, untreated contaminated group, ozone group, vancomycin group, and vancomycin + ozone group. Uncontaminated group underwent upper median sternotomy. The remaining four groups were inoculated with 0.5 mL 10(8) colony-forming units/mL methicillin-resistant Staphylococcus aureus in the mediastinal and sternal layers. Untreated contaminated group had no treatment. Rats in the vancomycin group received intramuscular vancomycin (40 mg/kg/d), and ozone was administered intraperitoneally (70 µg/mL, 1 mg/kg/d) in the ozone group for the treatment of mediastinitis. Vancomycin + ozone group rats were treated by the combination of both methods. At the end of 10 d, quantitative bacterial cultures and sternal tissue samples were obtained for determination of bacterial counts and histologic degree of inflammation. RESULTS: Both the vancomycin and the ozone treatments caused significant reduction of bacterial counts in quantitative bacterial cultures. Combination of vancomycin and ozone treatments resulted in further reduction of bacterial counts in mediastinum and sternum. Histologic examination of tissue samples revealed significant reduction in severity of mediastinitis related inflammation in vancomycin and vancomycin + ozone groups compared with untreated contaminated group. CONCLUSIONS: Ozone therapy as an adjunct to vancomycin leads to enhanced bacterial elimination in infected sternal and mediastinal tissues in experimental methicillin-resistant Staphylococcus aureus mediastinitis. The benefit of adjuvant ozone therapy is suggested to be related to its bactericidal effect.


Asunto(s)
Mediastinitis/tratamiento farmacológico , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Ozono/farmacología , Infecciones Estafilocócicas/tratamiento farmacológico , Esternón/microbiología , Vancomicina/farmacología , Animales , Antibacterianos/farmacología , Terapia Combinada , Modelos Animales de Enfermedad , Humanos , Mediastinitis/microbiología , Staphylococcus aureus Resistente a Meticilina/crecimiento & desarrollo , Distribución Aleatoria , Ratas , Ratas Wistar , Infecciones Estafilocócicas/microbiología , Esternón/cirugía , Infección de la Herida Quirúrgica/tratamiento farmacológico , Infección de la Herida Quirúrgica/microbiología , Resultado del Tratamiento
18.
J Wound Care ; 22(6): 324, 326-7, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24049817

RESUMEN

Chronic sternal infection is a relatively rare complication following cardiac surgery that can cause high morbidity and mortality and can require repeated surgical procedures, including sternal resection, to resolve. However, preserving sternal integrity is essential, particularly in children. A variety of conservative treatments for this complication of cardiac surgery have been reported. Here, we report three cases of children in whom a bone substitute containing tricalcium phosphate and hydroxyapatite was used to fill sternal defects. After extensive surgical debridement, this method yielded primary wound closure with good resolution, preventing the recurrence of sternal infection.


Asunto(s)
Sustitutos de Huesos/uso terapéutico , Fosfatos de Calcio/uso terapéutico , Procedimientos Quirúrgicos Cardíacos/efectos adversos , Durapatita/uso terapéutico , Fístula/etiología , Fístula/terapia , Esternón , Materiales Biocompatibles/uso terapéutico , Niño , Enfermedad Crónica , Femenino , Fístula/patología , Humanos , Control de Infecciones/métodos , Masculino , Esternotomía/efectos adversos , Esternón/microbiología , Esternón/patología , Infección de la Herida Quirúrgica/etiología , Infección de la Herida Quirúrgica/prevención & control , Cicatrización de Heridas
19.
J Clin Microbiol ; 50(1): 184-6, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22090399

RESUMEN

Sternal osteitis, a potential consequence of cardiac surgery, remains rare. The bacteria involved belong mostly to the genus Staphylococcus. Sternal infections caused by Serratia marcescens are exceptional. We report an unusual recurrence of sternal infection with S. marcescens, 15 years after the initial episode. The identities of the isolates were determined by genomic analysis.


Asunto(s)
Osteítis/diagnóstico , Osteítis/microbiología , Infecciones por Serratia/diagnóstico , Infecciones por Serratia/microbiología , Serratia marcescens/aislamiento & purificación , Análisis por Conglomerados , ADN Bacteriano/genética , Electroforesis en Gel de Campo Pulsado , Genotipo , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Tipificación Molecular , Osteítis/patología , Recurrencia , Infecciones por Serratia/patología , Esternón/microbiología , Esternón/patología
20.
Scand J Infect Dis ; 44(8): 623-5, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22497424

RESUMEN

We studied the incidence and characteristics of surgically treated sternocutaneous fistulas in a nationwide cohort of patients undergoing open heart surgery in Iceland. Between 2000 and 2010, sternocutaneous fistulas were treated surgically in 6 out of 2446 patients undergoing open heart surgery (incidence 0.25%, 95% confidence interval 0.11-0.53%). All patients were male, with a mean age of 71 ± 9 y. In addition to antibiotic treatment, debridement of the wound was performed in all cases. Staphylococcus aureus and/or coagulase-negative staphylococci were identified as pathogens in 5 cases and Candida albicans in 1. Chronic infections developed in 3 patients who were treated repeatedly, 1 of them unsuccessfully. In-hospital stay ranged from 0 to 50 days (mean 19 days). Sternocutaneous fistulas are rare, but since they may have a devastating course, increased awareness of this infectious complication of open heart surgery is important.


Asunto(s)
Procedimientos Quirúrgicos Cardíacos/efectos adversos , Fístula Cutánea/etiología , Esternón/cirugía , Infección de la Herida Quirúrgica/etiología , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Fístula Cutánea/microbiología , Humanos , Incidencia , Masculino , Estudios Prospectivos , Infecciones Estafilocócicas/etiología , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/aislamiento & purificación , Esternón/microbiología , Infección de la Herida Quirúrgica/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA